Since CD44 is also a surface marker of cancer stem cells (CSCs) [43], the sphere forming assay, which functionally assesses the presence of a stem cell population and the capability of reinitiate tumor formation, was carried out (Figure 6b). This evidence concerns the gene CD44 and neoplasm.